Zusammenfassung
Ökonomische Aspekte gewinnen in Anbetracht der demografischen und gesellschaftlichen Entwicklung auch in der Medizin zunehmend an Relevanz. Hierfür ist v. a. der Gegensatz zwischen einer kontinuierlich steigenden Nachfrage an medizinischen Leistungen bei zugleich zunehmend beschränkten medizinischen Ressourcen verantwortlich, der sowohl im stationären als auch im ambulanten Sektor zu beobachten ist. Um auch in Zukunft eine suffiziente und zugleich effiziente medizinische Versorgung sicherstellen zu können, ist ein grundlegendes Verständnis gesundheitsökonomischer Gegebenheiten sowie krankheitsspezifischer Aspekte unabdingbar. Hohe direkte Kosten fallen im Rahmen der Erstdiagnose, aber auch beim therapierefraktären Verlauf und beim Status epilepticus an. Die indirekten Kosten sind auf Arbeitslosigkeit, Frühberentung und krankheitsbedingte Fehltage sowie eine reduzierte Lebenserwartung zurückzuführen und weisen auf Verbesserungspotenziale in der Versorgung von Menschen mit Epilepsie hin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Beg JM et al. (2017) Burden of illness for super-refractory status epilepticus patients. J Med Econ 20:45–53
Forbes R (2008) Cost-utility of vagus nerve stimulation (VNS) therapy for medically refractory epilepsy – an update. Seizure 17:387–388
Helmers SL et al. (2011) Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy. Epilepsy Behav 22:370–375
Kortland LM et al. (2016) Costs and cost-driving factors for acute treatment of adults with status epilepticus: a multicenter cohort study from Germany. Epilepsia 57:2056–2066
Mitchell RJ et al. (2018) Examining health service utilization, hospital treatment cost, and mortality of individuals with epilepsy and status epilepticus in New South Wales, Australia 2012–2016. Epilepsy Behav 79:9–16
Picot MC et al. (2016) Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: a 5-year follow-up study. Epilepsia 57:1669–1679
Riechmann J et al. (2015) Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Epilepsia 56:1388–1397
Schubert-Bast S et al. (2019) Burden and epidemiology of status epilepticus in infants, children and adolescents: a population-based study on German health insurance data. Epilepsia 60(5):911–920
Strzelczyk A et al. (2017a) Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany. Epilepsia 58:1533–1541
Strzelczyk A et al. (2017b) The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using German health insurance data. Frontiers in neurology 8:712
Strzelczyk A et al. (2012) Evaluation of health-care utilization among adult patients with epilepsy in Germany. Epilepsy Behav 23:451–457
Strzelczyk A et al. (2008) Cost of epilepsy: a systematic review. PharmacoEconomics 26:463–476
Strzelczyk A et al. (2019) A multicenter, matched case‐control analysis comparing burden‐of‐illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany. Epilepsia 60:1697–1710
Thorbecke R et al. (2014) Effects of an inpatient rehabilitation program after temporal lobe epilepsy surgery and other factors on employment 2 years after epilepsy surgery. Epilepsia 55:725–733
Thurman DJ et al. (2017) The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League against Epilepsy. Epilepsia 58:17–26
Willems LM et al. (2018a) Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 – A ten-year overview. Epilepsy Behav 83:28–35
Willems LM et al. (2018b) Incidence, risk factors and cosequences of epilepsy-related injuries and accidents: a retrospective, single center study. Frontiers in Neurology 9:414
Willems LM et al. (2019) General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data. Appl Health Econ Health Policy 17:707–722
Zöllner JP et al. (2020) A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet J Rare Dis 15:23
Weiterführende Literatur
Wijnen BFM et al. (2017) A systematic review of economic evaluations of treatments for patients with epilepsy. Epilepsia 58:706–726
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Strzelczyk, A., Willems, L.M. (2020). Gesundheitsökonomie. In: Schmitt, F., Stefan, H., Holtkamp, M. (eds) Epileptische Anfälle und Epilepsien im Erwachsenenalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59198-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-59198-7_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59197-0
Online ISBN: 978-3-662-59198-7
eBook Packages: Medicine (German Language)